CTOs on the Move

Merrco Payments

www.merrco.ca

 
Merrco`s payment gateway technology provides a fully customizable method to regulate a direct‑to-consumer cannabis mail‑order system in Canada. This system ensures cannabis can only be sold to Canadians legally allowed to purchase, while eliminating any entry point for illicit‑market activity.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.merrco.ca
  • 179 John St. Suite 402
    Toronto, ON CAN M5T 1X4
  • Phone: 844.476.5726

Executives

Name Title Contact Details

Funding

Merrco Payments raised $30M on 10/25/2018

Similar Companies

Droshi AB

We at Droshi AB (formerly known as Scandinavian Dropshipping AB) strive to make online shopping inexpensive, risk free, and easy. Our developers constantly working toward improving our product for you. We began in 2015 when our founder got the idea from an American friend in Spain, where he lived in 2013. After having lost money on an online store, simply because his purchased inventory did not sell, he founded Droshi AB. When his American heard about his lost sales, his reaction was to laugh since, in the United States, more than 90% of all online stores use this particular concept. The Americans found an effective solution and see the traditional model as being inadequate.

MoreSteam

MoreSteam provides online training (e-Learning) and Blended Learning support tools and technology for Lean Six Sigma, Six Sigma and process improvement individuals, organizations, and deployments.

Bigtincan

Bigtincan transforms the way that field sales and service organizations access, interact with, present and collaborate on content, as well as how they engage with customers when using their mobile devices. Customer-facing teams empowered by Bigtincan better engage with their customers, selling more, faster, and drive higher customer satisfaction.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.

Pointivity

Pointivity is one of the leading providers in Software and Internet. It is based in San Diego, CA. To find more information about Pointivity, please visit www.pointivity.com.